Anavasi Diagnostics
Anavasi Diagnostics is dedicated to providing rapid, accurate, and affordable molecular diagnostic testing solutions for infectious diseases, including COVID-19. Their mission is to support healthcare providers and workplaces with high-quality testing technology that ensures safety, efficiency, and reliability. They focus on innovation, quality control, and supporting community health through advanced diagnostic tools.
Industries
Nr. of Employees
small (1-50)
Anavasi Diagnostics
Products
Portable reusable molecular detector and associated RT-LAMP NAAT
A portable, reusable detector system paired with an RT-LAMP–based nucleic-acid assay for qualitative detection of SARS-CoV-2 RNA at the point of care; designed for rapid turnaround, per-sample internal control, and multiplex target redundancy.
Portable reusable molecular detector and associated RT-LAMP NAAT
A portable, reusable detector system paired with an RT-LAMP–based nucleic-acid assay for qualitative detection of SARS-CoV-2 RNA at the point of care; designed for rapid turnaround, per-sample internal control, and multiplex target redundancy.
Services
Onboarding and clinical training for point-of-care diagnostics
Provision of training materials, personalized onboarding sessions, certification assessments, and deployment support to integrate molecular diagnostics into clinical workflows.
Secure cloud-based test data management and automated reporting
Cloud service that captures, stores, and automatically reports test results to public-health reporting streams; supports QR-code transmission and scan-based patient data entry.
Assay quality-control and validation support
Provision of QC documentation, routine assay quality testing, and collaboration with third-party laboratories to maintain assay performance against emerging variants.
Onboarding and clinical training for point-of-care diagnostics
Provision of training materials, personalized onboarding sessions, certification assessments, and deployment support to integrate molecular diagnostics into clinical workflows.
Secure cloud-based test data management and automated reporting
Cloud service that captures, stores, and automatically reports test results to public-health reporting streams; supports QR-code transmission and scan-based patient data entry.
Assay quality-control and validation support
Provision of QC documentation, routine assay quality testing, and collaboration with third-party laboratories to maintain assay performance against emerging variants.
Expertise Areas
- Point-of-care molecular diagnostics
- NAAT assay design and RT-LAMP implementation
- Multiplex genomic assay design and variant resiliency
- Variant surveillance and in silico coverage analysis
Key Technologies
- Reverse-transcription loop-mediated isothermal amplification (RT-LAMP)
- Nucleic acid amplification testing (NAAT)
- Fluorescence-based optical detection
- Multiplex genomic target design